Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Previous Opening Keynote: The Future of Rare Disease Trials You Might Also Like Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Aligning Trials with Patient-Lived Experiences Case Studies in Rare Disease Commercialization: Lessons Learned
Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Previous Opening Keynote: The Future of Rare Disease Trials You Might Also Like Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Aligning Trials with Patient-Lived Experiences Case Studies in Rare Disease Commercialization: Lessons Learned
